doi: 10.3389/fnut.2025.1581723 Received 22 February 2025 Accepted 25 April 2025 Published 05 June 2025 Volume 12 - 2025 Edited by Raul Avila-Sosa, Benemrita Universidad Autnoma de Puebla, Mexico Reviewed by Tales Fernando da Silva, Institute of Biological Sciences, Brazil Iaki Diez-Ozaeta, Spanish National Research Council (CSIC), Spain Vishnupriya Sethuraman, Bharathidasan University, India Jayani Kulathunga, University of Sri Jayewardenepura, Sri Lanka Rajni Devi, Punjab Agricultural University, India Updates Copyright 2025 Pandiyan, Gurung, Mulakala, Ponniah and Yeruva
2017), Trifolium (Cheng et al
& Millis, K
Preclinical safety profiles show no acute organ toxicity at doses far exceeding proposed human doses
This also leads to a loss of muscle mass, which further reduces metabolic rate